Kentucky
General Assembly

Search

Senate Bill 21

Actions | Amendments

Last Action	signed by Governor (Acts, ch. 65)
Title	AN ACT relating to use of experimental treatments for terminal illnesses.
Bill Documents	Current/Final Introduced
Bill Request Number	193
Sponsors	C. Embry Jr., J. Adams, M. Wilson
Summary of Original Version	Create new sections of KRS Chapter 217 to define terms; permit eligible patients to use investigational drugs, biological products, or devices for a terminal illness; establish the conditions for use of such experimental treatments; prohibit sanctions of health care providers; clarify the duties of health care insurers regarding experimental treatments; prohibit certain actions by state officials.
Index Headings of Original Version	Diseases - Investigational drugs, biological products, or devices, use by terminal patients Drugs and Medicines - Investigational drugs, biological products, or devices, use by terminal patients Health and Medical Services - Terminal patients, investigational drugs, biological products, or devices Nurses - Investigational drugs, bioloical products, or devices, use by terminal patients Pharmacists - Investigational drugs, biological products, or devices, use by terminal patients Physicians and Practitioners - Investigational drugs, biological products, or devices, use by terminal patients Public Health - Investigational drugs, biological products, or devices, use by terminal patients
Proposed Amendments	Senate Committee Substitute 1
Votes	Vote History

Actions

Top | Amendments

01/03/17	introduced in Senate
01/07/17	to Health & Welfare (S)
02/15/17	reported favorably, 1st reading, to Calendar with Committee Substitute
02/16/17	2nd reading, to Rules
02/17/17	posted for passage in the Regular Orders of the Day for Tuesday, February 21, 2017
02/21/17	3rd reading, passed 38-0 with Committee Substitute
02/22/17	received in House
02/27/17	to Health and Family Services (H)
03/01/17	posted in committee
03/02/17	reported favorably, 1st reading, to Calendar
03/03/17	2nd reading, to Rules
03/06/17	posted for passage in the Regular Orders of the Day for Tuesday, March 7, 2017
03/14/17	3rd reading, passed 87-7 received in Senate enrolled, signed by President of the Senate enrolled, signed by Speaker of the House delivered to Governor
03/21/17	signed by Governor (Acts, ch. 65)

Proposed Amendments

Top | Actions

Amendment	Senate Committee Substitute 1
Summary	Retain original provisions; remove language relating to informed consent in hospice care settings.
Index Headings	Diseases - Investigational drugs, biological products, or devices, use by terminal patients Drugs and Medicines - Investigational drugs, biological products, or devices, use by terminal patients Health and Medical Services - Terminal patients, investigational drugs, biological products, or devices Nurses - Investigational drugs, bioloical products, or devices, use by terminal patients Pharmacists - Investigational drugs, biological products, or devices, use by terminal patients Physicians and Practitioners - Investigational drugs, biological products, or devices, use by terminal patients Public Health - Investigational drugs, biological products, or devices, use by terminal patients

Last updated: 1/16/2019 3:02 PM (EST)